Eugui EM - Search Results

1

Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).

Allison AC, Eugui EM. Allison AC, et al. Among authors: eugui em. Clin Transplant. 1996 Feb;10(1 Pt 2):77-84. Clin Transplant. 1996. PMID: 8680053 Review.

2

Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism.

Chanaud NP 3rd, Vistica BP, Eugui E, Nussenblatt RB, Allison AC, Gery I. Chanaud NP 3rd, et al. Exp Eye Res. 1995 Oct;61(4):429-34. doi: 10.1016/s0014-4835(05)80138-1. Exp Eye Res. 1995. PMID: 8549684

3

Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.

Allison AC, Eugui EM. Allison AC, et al. Among authors: eugui em. Transplantation. 2005 Oct 15;80(2 Suppl):S181-90. doi: 10.1097/01.tp.0000186390.10150.66. Transplantation. 2005. PMID: 16251851 Review.

4

Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines.

Cohn RG, Mirkovich A, Dunlap B, Burton P, Chiu SH, Eugui E, Caulfield JP. Cohn RG, et al. Transplantation. 1999 Aug 15;68(3):411-8. doi: 10.1097/00007890-199908150-00014. Transplantation. 1999. PMID: 10459546

5

Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells.

Senda M, DeLustro B, Eugui E, Natsumeda Y. Senda M, et al. Transplantation. 1995 Nov 27;60(10):1143-8. doi: 10.1097/00007890-199511270-00015. Transplantation. 1995. PMID: 7482723

6

DAB486-IL-2 (IL-2-toxin) in combination with low-dose RS-61443 (mycophenolate mofetil) prolongs murine thyroid allograft survival.

Hullett DA, Landry AS, Eckhoff DE, Nichols JC, Eugui EM, Allison AC, Sollinger HW. Hullett DA, et al. Among authors: eugui em. Transplant Proc. 1993 Feb;25(1 Pt 1):756-7. Transplant Proc. 1993. PMID: 8438470 No abstract available.

7

Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis.

Morris RE, Hoyt EG, Murphy MP, Eugui EM, Allison AC. Morris RE, et al. Among authors: eugui em. Transplant Proc. 1990 Aug;22(4):1659-62. Transplant Proc. 1990. PMID: 2389428 No abstract available.

8

The design and development of an immunosuppressive drug, mycophenolate mofetil.

Allison AC, Eugui EM. Allison AC, et al. Among authors: eugui em. Springer Semin Immunopathol. 1993;14(4):353-80. doi: 10.1007/BF00192309. Springer Semin Immunopathol. 1993. PMID: 8322167 Review. No abstract available.

9

Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation.

Allison AC, Eugui EM. Allison AC, et al. Among authors: eugui em. Transplant Proc. 1994 Dec;26(6):3205-10. Transplant Proc. 1994. PMID: 7998117 Review. No abstract available.

10

Lymphocyte-selective antiproliferative and immunosuppressive activity of mycophenolic acid and its morpholinoethyl ester (RS-61443) in rodents.

Eugui EM, Mirkovich A, Allison AC. Eugui EM, et al. Transplant Proc. 1991 Apr;23(2 Suppl 2):15-8. Transplant Proc. 1991. PMID: 2063416 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results